1. Home
  2. news

News

Featured
NewYorkBIO Responds to Proposed NIH Fu…
Read All About It

Latest News

NewYorkBIO, New York City Economic Development Corporation, & Empire State Development Partner to Launch New York Bio Connect
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland on ORPHAN Cures Act
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO 
NewYorkBIO Responds to Most Favored Nation Executive Order
Statement on behalf of Jennifer Hawks Bland, CEO of NewYorkBIO on Most Favored Nation Executive Order
MidAtlantic Bio Angel and NewYorkBIO Forge Strategic Partnership for 2025
New York, NY (April 23, 2025) – Mid Atlantic Bio Angels Group (MABA) and NewYorkBIO announced today a…
Statement from Jennifer Hawks Bland on National Security Commission on Emerging Biotechnology Report
NewYorkBIO joins BIO in expressing our gratitude to NSCEB for their years-long work to examine and present…
Statement on Behalf of Jennifer Hawks Bland on Proposed Tariffs
Statement on Behalf of Jennifer Hawks Bland on Proposed Tariffs
NewYorkBIO Welcomes Brian Dershowitz as Vice President of Strategic Partnerships & Initiatives
NewYorkBIO Welcomes Brian Dershowitz as Vice President of Strategic Partnerships & Initiatives
Show More News

Savings Partners

RSS feeds source logo StatNews StatNews
STAT+: What to expect at the ASH meeting, and some thoughts on the FDA’s Richard Pazdur
12/04/2025
What to expect at the annual ASH conference, and some thoughts on FDA's Richard Pazdur.
STAT+: FDA to lower number of trials required for approval of drugs, other medical products
12/04/2025
The FDA plans to begin requiring one clinical study, instead of the standard two, for medical ...
STAT+: Hair loss drug succeeds in Phase 3, but data underwhelms experts
12/03/2025
A topical hair loss medication successfully built up hair in a Phase 3 trial, according to the ...
STAT+: Startup aims to combine AI with new small molecule technology
12/03/2025
And more biotech news updates, brought to you by The Readout
STAT+: Capricor says its cell therapy improved heart and muscle function in Duchenne patients
12/03/2025
Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart ...
STAT+: Aging startup backed by Sam Altman chases $5 billion valuation
12/03/2025
Retro Bio, a longevity startup backed by OpenAI CEO Sam Altman, is close to raising what could be ...
STAT+: A drug that was ‘engineered with AI’ enters Phase 3 testing
12/02/2025
And more biotech news, brought to you by The Readout newsletter
STAT+: Vinay Prasad’s ‘extraordinary’ memo about vaccine policy
12/01/2025
And more biotech news, brought to you by the The Readout newsletter.
STAT+: Sarepta cleared to test new safety regimen for Duchenne drug
11/26/2025
And more biotech news brought to you by The Readout